| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.61B | +0.1% |
| Cost of Revenue | $2.11B | +16.5% |
| R&D Expense | $1.91B | -9.4% |
| SG&A Expense | $857.4M | -10.1% |
| Operating Income | -$1.40B | -0.2% |
| Interest Expense | $22.0M | +2.6% |
| Pre-tax Income | -$1.29B | +7.6% |
| Income Tax | $28.1M | -3.1% |
| Net Income | -$1.32B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.78B | +25.1% |
| Short-term Investments | $1.76B | -29.9% |
| Accounts Receivable | $1.28B | +8.0% |
| Current Assets | $4.98B | -5.3% |
| Total Assets | $7.97B | -0.8% |
| Current Liabilities | $1.13B | -6.7% |
| Long-term Debt | $3.75B | +0.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $246.5M | +33.5% |
| Capital Expenditures | $211.7M | +63.7% |
| Investing Cash Flow | $571.0M | +153.7% |
| Financing Cash Flow | -$458.8M | -249.6% |
| Free Cash Flow | $34.8M | -37.1% |
| +7.5% |
| EPS (Basic) | -$0.82 | +7.9% |
| EPS (Diluted) | -$0.82 | +7.9% |
| Total Liabilities |
| $5.55B |
| +1.9% |
| Stockholders' Equity | $2.41B | -6.5% |